Board Member Kalesnik Buys 25,000 RSUs, Signaling Confidence in Verano’s Cannabis Growth Plan

Insider Activity Signals Confidence Amid a Bullish Trend On March 16, 2026, Verano Holdings Corp‑NV (VRNO) saw a notable insider transaction: Kalesnik Laura Marie, the company’s board member, exercised a grant of 25,000 restricted stock units that will vest into common stock. Although the units have not yet settled, the transaction reflects an additional 25,000 shares being added to her ownership base, raising her post‑deal holdings to 376,388 shares. This move comes as the stock trades at $1.192, a modest 0.01 % increase on the day, while overall market sentiment around the ticker is neutral and social‑media buzz remains below average (10.35 %).

What the Buy Could Mean for Investors A board member’s purchase—particularly of newly granted RSUs—often signals confidence in the company’s trajectory. In Verano’s case, the transaction aligns with recent analyst endorsements: Canaccord Genuity and other research firms have maintained buy ratings and favorable price targets. The company’s 52‑week high of $1.95, coupled with a 7.14 % weekly rise and a 15.5 % monthly gain, suggests a rally that may continue if the company delivers on its expansion plans. Investors may interpret Kalesnik’s buy as a vote of confidence that the company’s cannabis retail and cultivation strategies will sustain growth, especially given the firm’s diversified brand portfolio and strategic positioning in the U.S. market.

Kalesnik Laura Marie: A Transaction Profile Kalesnik’s insider activity over the past year paints a picture of an active participant in the company’s equity plan. In December 2025, she sold 5,850 shares at $0.95 and 25,465 shares at $0.91, while also buying 104,571 shares at $0.00—an acquisition that increased her stake to 382,703 shares. She has also liquidated multiple RSU grants, selling 66,341, 27,250, and 10,980 units in early December, reducing her post‑transaction holdings to 200,389 shares. The pattern of buying during periods of low share price and selling after vesting suggests a long‑term investment horizon, with a willingness to lock in gains when the market appreciates. Her recent purchase of additional RSUs indicates that she believes the company will continue to outperform and that the stock will likely rise above its current 52‑week low of $0.41.

Implications for Verano’s Future With a market cap of roughly $405 million and a recent upward swing, Verano is positioned to capitalize on the expanding legal cannabis market. The board’s active participation—particularly Kalesnik’s buy—could reassure market participants that management’s interests are aligned with shareholders. If the company’s operational metrics, such as retail expansion and product differentiation, continue to strengthen, the stock may sustain its bullish trajectory. However, investors should remain mindful of the sector’s regulatory risks and the volatility typical of OTC‑listed cannabis stocks.

Bottom Line Kalesnik Laura Marie’s purchase of RSUs is a modest yet meaningful indicator of insider confidence. Coupled with favorable analyst coverage and a healthy price run, the transaction signals that the board expects Verano Holdings to navigate the competitive cannabis landscape successfully. For investors, it is a cue to monitor the stock’s performance as the company rolls out its growth strategy and to consider whether the current valuation reflects the underlying fundamentals and growth prospects.